Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: Implications for adjuvant radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 5, 2003, Pages 1272-1276

  Murphy, Kevin T ^a   Rotmensch, Jacob ^a   Yamada, S Diane ^a   Mundt, Arno J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Clear cell carcinoma; Endometrial cancer; Radiation therapy

Indexed keywords

CELLS; CYTOLOGY; HORMONES; PATHOLOGY; RADIOTHERAPY; SURGERY;

CARCINOMA;

ONCOLOGY;

HORMONE;

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLEAR CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HISTOLOGY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; PELVIS; PRIORITY JOURNAL; RELAPSE; SAMPLING; TREATMENT FAILURE; TREATMENT OUTCOME; UTERUS SARCOMA; VAGINA;

EID: 0037377042     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04404-8     Document Type: Article

References (30)

1. Landis S.H., Murray T., Bolden S., et al. Cancer statistics. CA Cancer J Clin. 49:1999;8-31.
2. Abeler V.M., Kjorstad K.E. Clear cell carcinoma of the endometrium A histopathological and clinical study of 97 cases. Gynecol Oncol. 40:1991;207-217.
3. Abeler V.M., Vergote I.B., Kjorstad K.E., et al. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer. 78:1996;1740-1747.
4. Christopherson W.M., Alberhasky R.C., Connelly P.J. Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer. 49:1982;1511-1523.
5. Cirisano F.D. Jr, Robboy S.J., Dodge R.K., et al. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol. 77:2000;55-65.
6. Photopulos G.J., Carney C.N., Edelman D.A., et al. Clear cell carcinoma of the endometrium. Cancer. 43:1979;448-456.
7. Webb G.A., Lagios M.D. Clear cell carcinoma of the endometrium. Am J Obstet Gynecol. 156:1987;1486-1491.
8. Carcanigu M.L., Chambers J.T. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium Comparison of clinicopathologic features and survival. Int J Gynecol Pathol. 14:1995;30-38.
9. Malpica A., Tornos C., Burke T.W., et al. Low-stage clear-cell carcinoma of the endometrium. Am J Surg Pathol. 19:1995;769-774.
10. Smith R., Kapp D., Chen Q., et al. Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol. 48:2000;767-778.
11. Craighead P.S., Sait K., Stuart G.C., et al. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994. Gynecol Oncol. 77:2000;248-253.
12. Sakuragi N., Hareyama H., Todo Y., et al. Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma. Acta Obstet Gynecol Scand. 79:2000;311-316.
13. Sigurdsson K., Sigurdardottir B., Steinsson S., et al. Survival and prognostic factors of endometrial cancer patients in Iceland 1964-1985 Can attendance at population-based pap-smear screening affect survival? Int J Cancer. 79:1998;166-174.
14. Aquino-Parsons C., Lim P., Wong F., et al. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma Treatment implications. Gynecol Oncol. 71:1998;83-86.
15. Carinelli S.G., Senzani F. Clear cell carcinoma of endometrium. Tumori. 65:1979;201-205.
16. Giri P.G., Schneider V., Belgrad R. Clear cell carcinoma of the endometrium An uncommon entity with a favorable prognosis. Int J Radiat Oncol Biol Phys. 7:1981;1383-1387.
17. Kanbour-Shakir A., Tobon H. Primary clear cell carcinoma of the endometrium A clinicopathologic study of 20 cases. Int J Gynecol Pathol. 10:1991;67-78.
18. DeBonnelle H.E. Uber einig falle von carcinoma corpus uteri mit viel glykogen. Virechows Arch (Pathol Anat). 204:1911;201-209.
19. Corpus cancer staging. Int J Gynecol Obstet. 28:1989;16.
20. Poulsen H., Taylor C.W., Sobin L.H. International histologic classification of tumors. No. 13. Histologic typing of female genital tract tumors. 1975;World Health Organization, Geneva.
21. Kurman R.J., Scully R.E. Clear cell carcinoma of the endometrium An analysis of 21 cases. Cancer. 37:1976;872-882.
22. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 50:1960;163-170.
24. Silverberg S.G., De Giorgi L.S. Clear cell carcinoma of the endometrium. Clinical, pathologic, and ultrastructural findings. Cancer. 31:(5):1973;1127-1140.
25. Yamawaki T., Teshima H., Takeshima N., et al. A clinicopathological study in clear cell adenocarcinoma of the endometrium. Nippon Sanka Fujinka Gakkai Zasshi. 48:1996;328-334.
26. Alektiar K.M., McKee A.B., Zelefsky M.J., et al. Is there a difference in outcome between stage I-II endometrial cancer of papillary serous (PS)/clear cell (CC) histologies and endometrioid FIGO grade 3. Int J Radiat Oncol Biol Phys. 54:2002;79-85.
27. Roeske J., Lujan A., Rotmensch J., et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 48:2000;1613-1621.
28. Mundt A.J., Lujan A., Rotmensch J., et al. Intensity modulated whole pelvic radiation therapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 52:2002;1330-1337.
29. Mundt A.J., Roeske J., Lujan A., et al. Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies. Gynecol Oncol. 82:2001;456-463.
30. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys. 51:2001;261-266.